What is the Imugene (ASX: IMU) share price?
The IMU share price is $0.115, up 21.05% for the day, based on the latest available ASX market data.
What is Imugene's market capitalisation?
Imugene has a market capitalisation of $47.8M, making it the 1035th-largest security listed on the ASX.
Does Imugene pay a dividend?
IMU does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
Is Imugene profitable?
In its most recent reported period (ending 31 Dec 2025), IMU reported revenue of $0 and a net loss of $37.8M.
How many IMU shares are on issue?
Imugene has approximately 415,835,000 shares on issue, based on its market capitalisation of $47.8M and current share price.
What sector is Imugene in?
Imugene is classified in the Healthcare sector, within the Biotechnology industry on the ASX.
When did Imugene list on the ASX?
Imugene listed on the Australian Securities Exchange on 31 Dec 1998.
